Medicine and Dentistry
Neoplasm
100%
Breast Cancer
79%
Pancreas Adenocarcinoma
78%
Pancreas Cancer
68%
Cancer Cell
44%
Disease
41%
Tumor Suppressor Protein
27%
Caveolin 1
27%
Metastatic Carcinoma
25%
Retinoblastoma
25%
Tumor Progression
24%
Stroma
24%
Carcinogenesis
22%
Malignant Neoplasm
22%
Tumor Microenvironment
19%
Cancer Associated Fibroblast
18%
Cell Cycle
18%
Pancreas Carcinoma
18%
P16
17%
Triple Negative Breast Cancer
16%
Surgery
16%
Warburg Effect
16%
Cancer Growth
16%
Immunohistochemistry
16%
Gemcitabine
16%
Intraductal Carcinoma
15%
Recurrent Disease
15%
Magnetic Resonance Imaging
15%
Tumor Cell
14%
Targeted Therapy
14%
Autophagy
14%
Personalized Medicine
14%
Lactic Acid
13%
Treatment Response
13%
Tumor Recurrence
12%
Aerobic Glycolysis
12%
Mitochondrial Respiration
12%
Gene Expression Profiling
11%
Deoxycytidine Kinase
11%
Overall Survival
11%
Intraductal Papillary Mucinous Tumor
11%
Stromal Cell
11%
Receptor Expression
10%
Epidermal Growth Factor Receptor
10%
Progression Free Survival
10%
Breast Tumor
10%
Lymph Node
10%
Pembrolizumab
10%
Nodular Melanoma
10%
Hyperplasia
10%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
84%
Tumor Suppressor Protein
69%
Retinoblastoma
52%
Caveolin 1
49%
Cell Cycle
47%
Mouse
37%
Fibroblast
36%
Genetics
33%
Tumor Progression
29%
Estrogen Receptor
29%
Gene Expression
28%
Autophagy
27%
Carcinogenesis
25%
P16
25%
Gene Expression Profiling
24%
KRAS
22%
Gemcitabine
20%
Proliferating Cell Nuclear Antigen
20%
Cyclin
20%
Overall Survival
18%
Cell Cycle Progression
17%
Tumor Suppressor Gene
16%
Explant
15%
Vascular Endothelial Growth Factor
15%
Cyclin D1
15%
Warburg Effect
15%
Metabolic Pathway
14%
Cyclin-Dependent Kinase 4
14%
Kinase
13%
P53
12%
Epidermal Growth Factor Receptor
12%
Deoxycytidine Kinase
12%
Secretion (Process)
12%
Phosphotransferase
12%
Cyclin-Dependent Kinase
11%
Cell Growth
11%
Mitochondrial Respiration
11%
Eicosanoid Receptor
10%
S Phase
10%
NFE2L2
10%
Genetic Divergence
10%
Prolactin
10%
Signal Transduction
9%
Mouse Model
9%
Immune Checkpoints
9%
Multivariate Analysis
9%
Oncogene
8%
Allele
8%
Tyrosine
8%
Immunostaining
8%
Keyphrases
Cyclin-dependent Kinase 4 (CDK4)
44%
Pancreatic Cancer
26%
Caveolin-1 (Cav-1)
25%
Cancer-associated Fibroblasts
22%
Human Breast Cancer
20%
Pancreatic Ductal Adenocarcinoma
19%
Tumor
17%
Chemotherapy
15%
Tumor Microenvironment
13%
Tumor Stroma
12%
Ductal Carcinoma in Situ
11%
Graft-versus-host Disease (GvHD)
10%
Pancreatic Carcinoma
10%
Malignant Melanoma
10%
Magnetic Resonance Imaging
10%
Combined Small Cell Lung Cancer (CSCLC)
10%
Cancer Cells
10%
Cyclin-dependent Kinase 4/6 Inhibitors
9%
Breast Cancer Patients
8%
Autophagy
8%
Progression-free Survival
8%
Palbociclib
8%
Metastatic Melanoma
8%
In Cancer
8%
Cyclin-dependent Kinase
8%
Metastasis
7%
Cyclin-dependent Kinase Inhibitor
7%
Stromal Fibroblasts
7%
Retinoblastoma
7%
RB Pathway
7%
Poor Clinical Outcomes
6%
Treatment Strategy
6%
Forkhead Box P3 (FOXP3)
6%
Oxidative Stress
6%
Tumor-promoting
6%
Triple-negative Breast Cancer
6%
Tumor Recurrence
6%
Aromatase Inhibitors
6%
Tamoxifen Resistance
6%
Functional Determinants
6%
Antitumor Activity
6%
Autophagy Inhibitor
6%
Tumor Growth
6%
Protein Expression
6%
Gemcitabine
6%
Monocarboxylate Transporter 4 (MCT4)
6%
Immune Checkpoint
6%
Signaling Pathway
5%
Recurrent Disease
5%
Prostate Cancer
5%
